Encompass Health (EHC) Cash & Equivalents (2009 - 2026)

Encompass Health has reported Cash & Equivalents for 18 years, with the latest figure at $110.5 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 15.34% year-over-year to $110.5 million; the trailing twelve-month figure through Mar 2026 stood at $110.5 million (up 15.34% YoY), and the FY2025 full-year result was $72.2 million, down 15.46% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $110.5 million, up from $72.2 million in the prior quarter.
• The five-year high for Cash & Equivalents was $154.4 million in Q2 2024, with the low at $21.8 million in Q4 2022.
• Historically, Cash & Equivalents has averaged $94.9 million across 5 years, with a median of $95.8 million in 2025.
• Annual changes were most pronounced in 2023 — Cash & Equivalents jumped 216.97% — and 2025, when it tumbled 67.05%.
• Encompass Health's Cash & Equivalents stood at $21.8 million in 2022, then jumped by 216.97% to $69.1 million in 2023, then climbed by 23.59% to $85.4 million in 2024, then dropped by 15.46% to $72.2 million in 2025, then jumped by 53.05% to $110.5 million in 2026.
• The last three Cash & Equivalents figures came in at $110.5 million (Q1 2026), $72.2 million (Q4 2025), and $48.7 million (Q3 2025), per Business Quant data.